You will find here the information about the opportunities of
rare diseases research funding at the national level in «National RD funding initiatives» and «Next generation sequencing facilities database» that groups sequencing platforms from Europe and Associated countires.
Since 2006, E-Rare has become one of the major contributors to transnational
rare diseases research funding.
Next to performing Joint Transnational Calls and assessment of the funding mechanisms and results of the funded research projects the E-Rare-1 and E-Rare-2 programmes paid attention to deepening the cooperation and coordination among the E-Rare partners by systematic exchange of information on the national programmes and by strategic activities aimed at a sustainable development and extension of the network of
rare disease research funders.
Not exact matches
Because this form of cancer is
rare, even the Complaint acknowledged that it was difficult for Dr. Taub to get
funding to conduct
research on a
disease that causes so much pain and suffering.
Congressman Chris Collins, along with local medical experts and families living with
rare diseases, urged members of the U.S. Senate to pass legislation that boosts
funds for
research.
And in the United States, the National Human Genome
Research Institute in Bethesda, Maryland, recently
funded three Mendelian Disorders Sequencing Centers that will apply genome sequencing to diagnosing thousands of patients with a wider range of
rare diseases, including intellectual disability and developmental delay.
«Steep
funding cuts for the federal health agencies are counterproductive at a time when innovative
research is moving us closer to identifying solutions for
rare diseases, new prevention strategies to protect Americans from deadly and costly conditions, advances in gene therapy, new technologies for understanding the brain, and treatments that harness the ability of our immune system to fight cancer.»
The researchers conducted a survey of 210 patients with physician - diagnosed mitochondrial
disease recruited through the National Institutes of Health -
funded Rare Diseases Clinical
Research Network.
European Journal of Human Genetics has published a key publication describing the achievements of three flagship EU -
funded projects — RD - Connect, NeurOmics and EURenOmics — and how they are shaping the
rare disease research environment in Europe and globally.
Funding organizations (i.e., funding bodies, groups of funders (for small funders), companies) investing more than 10 million USD over 5 years in rare disease r
Funding organizations (i.e.,
funding bodies, groups of funders (for small funders), companies) investing more than 10 million USD over 5 years in rare disease r
funding bodies, groups of
funders (for small
funders), companies) investing more than 10 million USD over 5 years in
rare disease research
Survey and Strategic Analysis on Future Themes and Needs for
Rare Diseases Research Funding In the European Council recommendation on rare diseases (RD), Member States ar
Rare Diseases Research Funding In the European Council recommendation on
rare diseases (RD), Member States ar
rare diseases (RD), Member States are...
EURenOmics is collaborating with E-
Rare, a consortium built to link responsible
funding bodies that combine the scarce resources and
fund rare disease research via Joint Transnational Calls.
Her current
research is focused on the identification of genes and molecular pathways for
rare disorders and she is the Lead Investigator of the Genome Canada, CIHR funded «Finding of Rare Disease Genes in Canada» (FORGE Canada) and «Enhanced CARE for RARE Genetic Diseases in Canada» initiati
rare disorders and she is the Lead Investigator of the Genome Canada, CIHR funded «Finding of Rare Disease Genes in Canada» (FORGE Canada) and «Enhanced CARE for RARE Genetic Diseases in Canada» initiati
rare disorders and she is the Lead Investigator of the Genome Canada, CIHR
funded «Finding of
Rare Disease Genes in Canada» (FORGE Canada) and «Enhanced CARE for RARE Genetic Diseases in Canada» initiati
Rare Disease Genes in Canada» (FORGE Canada) and «Enhanced CARE for RARE Genetic Diseases in Canada» initiati
Rare Disease Genes in Canada» (FORGE Canada) and «Enhanced CARE for
RARE Genetic Diseases in Canada» initiati
RARE Genetic Diseases in Canada» initiati
RARE Genetic Diseases in Canada» initiatives.
This tool is one of the main outcomes of RD - Connect, the EU -
funded project that has built a community of patients, clinicians, researchers and bioinformaticians in Europe and beyond, and has advanced collaboration and data sharing to facilitate and accelerate
research for
rare diseases.
Summary: A two day meeting to demonstrate to the wider scientific community where the IMPC is trying to go and how to include clinical scientists, geneticists and the
rare disease research community, followed by two simultaneous one day workshops (phenotyping and EUCOMMTOOLS) to plan for Phase II phenotyping and discuss production technology development Attended by: IMPC members, corporate sponsors, external delegates, EUCOMMTOOLS members and IKMC members Hosted /
funded by: Infrafrontier, EUCOMMTOOLS, CNR Monterotondo
That quick turnaround is particularly important for
rare and orphan
diseases, those that affect fewer than 200,000 people nationwide, because families and family - run foundations typically
fund that
research and they do so against a ticking clock — the life of their loved one.
The goal of IRDiRC is to team up researchers and
funding organizations across the world that are strongly involved in
rare diseases research in order to achieve two main and ambitious objectives: deliver 200 new therapies for
rare diseases and means to diagnose most
rare diseases by the year 2020.
About the International
Rare Diseases Research Consortium (IRDiRC): IRDiRC was formed to unite public and private sector funders of research, patient advocacy groups, and scientific researchers to advance rare diseases research worldw
Rare Diseases Research Consortium (IRDiRC): IRDiRC was formed to unite public and private sector funders of research, patient advocacy groups, and scientific researchers to advance rare diseases research wo
Research Consortium (IRDiRC): IRDiRC was formed to unite public and private sector
funders of
research, patient advocacy groups, and scientific researchers to advance rare diseases research wo
research, patient advocacy groups, and scientific researchers to advance
rare diseases research worldw
rare diseases research wo
research worldwide.
The successful linking of
research funding organizations in E-
Rare-1 and the subsequent exemplary joint
funding activities have attested the need of, and the acknowledgment from, the
research community for transnational
funding of collaborative, multidisciplinary and ambitious projects on
rare diseases.
Funded as part of the EU's commitment to the International
Rare Diseases Research Consortium (IRDiRC), RD - Connect is a global infrastructure project that links omics data with databases, registries, biobanks, and clinical bioinformatics tools into a central research resource for rare disea
Rare Diseases Research Consortium (IRDiRC), RD - Connect is a global infrastructure project that links omics data with databases, registries, biobanks, and clinical bioinformatics tools into a central research resource for rare d
Research Consortium (IRDiRC), RD - Connect is a global infrastructure project that links omics data with databases, registries, biobanks, and clinical bioinformatics tools into a central
research resource for rare d
research resource for
rare disea
rare diseases.